US Patent Issued to NANO TARGETING & THERAPY BIOPHARMA on April 15 for "Silica nanosphere for immunotherapy" (Taiwanese Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,755, issued on April 15, was assigned to NANO TARGETING & THERAPY BIOPHARMA INC. (Taipei, Taiwan).

"Silica nanosphere for immunotherapy" was invented by Chung-Yuan Mou (Taipei, Taiwan), Cheng-Hsun Wu (Zhubei, Taiwan), Si-Han Wu (Taoyuan, Taiwan) and Yi-Ping Chen (Keelung, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a field of hollow silica nanospheres. Particularly, the present disclosure relates to silica nanoparticles as adjuvant to induce or enhance immune response or as carrier to deliver antigen to a body."

The patent was filed on July 17, 2020, under Application No. 16/932,380.

*For further informat...